A complete application in a minute
Tailored resume and cover letter, ready to send.
The American Association for Cancer Research (AACR) invites applications for an Assistant/Associate Editor for Blood Cancer Discovery. The editor will oversee manuscript submissions, commission reviews, and edit for publication; promote the journal through outreach and networking.
A highly visible role within AACR and the cancer research community is expected. The position may be based in an AACR office in Boston or Philadelphia, with responsibilities spanning hematologic malignancies and
The American Association for Cancer Research (AACR) has an exciting opportunity for a scientist with strong research experience and communications skills to join the editorial team of Blood Cancer Discovery. The journal provides a premier platform of research communication on leukemia, lymphoma, myeloma, and associated diseases and is grounded in the same principles that led to success of Cancer Discovery, the AACR flagship journal with impact factor of 29.5, rigorous selection of research of highest quality and significance, fast and fair editorial process, and active promotion of published content.
The Assistant/Associate Editor, Blood Cancer Discovery, will handle manuscript submissions throughout the review process. This person will also commission reviews and other content, write and edit for the journal and promote the journal through outreach and networking efforts. As a key member of the publications group, the Assistant/Associate Editor, Blood Cancer Discovery will have a highly visible role both within the Association and in the larger cancer research community.
The position may be based in an AACR office in Boston or Philadelphia.
Blood Cancer Discovery is a leading journal dedicated to publishing major advances in leukemia, lymphoma, myeloma, and other hematologic malignancies. The journal features high-impact basic, translational, and clinical research that advances the understanding of disease mechanisms, identifies novel therapeutic opportunities, and informs precision medicine approaches for patients. It also publishes insightful reviews, perspectives, and commentaries that highlight emerging trends, unresolved challenges, and future directions in hematologic oncology.